StockData
Bicara Therapeutics Inc. logo

Bicara Therapeutics Inc. (BCAX) income statement

BCAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$8.44−0.68 (-7.46%)

Close on Nov 20, 2026Market cap $558.50MP/E –Yield –

See a number that looks wrong?